|
[Related PubMed/MEDLINE]
Total Number of Papers: 40
|
|
|
| |
|
[Entries Per Page]
|
|
per page
|
| |
|
Page Control
|
|
|
| Page: of |
|
|
|
| No. |
Year |
Title |
Co-occurring Abbreviation |
| 1 |
2020 |
First-in-Human Phase I Study to Evaluate the Brain-Penetrant PI3K/mTOR Inhibitor GDC-0084 in Patients with Progressive or Recurrent High-Grade Glioma. |
PK |
| 2 |
2020 |
Hybrid positron emission tomography imaging for initial staging of sinonasal tumors: Total lesion glycolysis as prognosticator of treatment response. |
CR, DM, PET, TLG |
| 3 |
2020 |
On the conundrum of cognitive impairment due to depressive disorder in older patients. |
AD, Am-PET, CSF, DD, HC |
| 4 |
2020 |
The evolution of parkinsonism in primary progressive apraxia of speech: A 6-year longitudinal study. |
CBS, PPAOS, PSP |
| 5 |
2019 |
Application of T1-/T2-Weighted Ratio Mapping to Elucidate Intracortical Demyelination Process in the Alzheimer's Disease Continuum. |
AD, CSF, HP, IPL, MCI, PET, SUVR |
| 6 |
2019 |
Neuroimaging correlates with neuropathologic schemes in neurodegenerative disease. |
PiB-PET |
| 7 |
2019 |
Recent Advancement and Clinical Implications of 18FDG-PET in Parkinson's Disease, Atypical Parkinsonisms, and Other Movement Disorders. |
AP, HD, PD |
| 8 |
2019 |
Recent developments in penile cancer imaging. |
CT, SNB, SPECT |
| 9 |
2018 |
Effect of radiochemotherapy on T2* MRI in HNSCC and its relation to FMISO PET derived hypoxia and FDG PET. |
GTV, LN, nonHSV, RCT |
| 10 |
2017 |
Early functional network alterations in asymptomatic elders at risk for Alzheimer's disease. |
AD, FC |
| 11 |
2017 |
Multimodal Fingerprints of Resting State Networks as assessed by Simultaneous Trimodal MR-PET-EEG Imaging. |
DMN, MRS |
| 12 |
2017 |
Spontaneous low frequency BOLD signal variations from resting-state fMRI are decreased in Alzheimer disease. |
AD, fMRI, NC, NEC, rs-fMRI, SUVR |
| 13 |
2016 |
Impact of Common Variations in PLD3 on Neuroimaging Phenotypes in Non-demented Elders. |
AD, ADNI, CMRgl, MCI, MRI, NC, PLD3 |
| 14 |
2016 |
Metabolic spatial connectivity in amyotrophic lateral sclerosis as revealed by independent component analysis. |
ALS, ICA, PET, VOI |
| 15 |
2016 |
Multimodal Classification of Mild Cognitive Impairment Based on Partial Least Squares. |
AD, ADNI, MCI, MRI, PLS, RF, SVM |
| 16 |
2016 |
Plasma vesicle miRNAs for therapy response monitoring in Hodgkin lymphoma patients. |
cHL, EVs, exRNA, miRNAs, SEC, STW |
| 17 |
2016 |
The Neural Basis of Postural Instability Gait Disorder Subtype of Parkinson's Disease: A PET and fMRI Study. |
BA, FC, PIGD, TD |
| 18 |
2015 |
Relationship between simultaneously acquired resting-state regional cerebral glucose metabolism and functional MRI: a PET/MR hybrid scanner study. |
DC, fALFF, GM, ReHo |
| 19 |
2014 |
FDG-PET and amyloid-PET imaging: the diverging paths. |
--- |
| 20 |
2014 |
Imaging Brain Metabolism and Pathology in Alzheimer's Disease with Positron Emission Tomography. |
AD, CMRglc, PET |
| 21 |
2013 |
Churg-Strauss syndrome cardiac involvement evaluated by cardiac magnetic resonance imaging and positron-emission tomography: a prospective study on 20 patients. |
CMRI, CSS, MDE |
| 22 |
2013 |
Homonymous hemianopia in nonketotic hyperglycemia is an ictal phenomenon. |
--- |
| 23 |
2012 |
Apathy in patients with Parkinson disease without dementia or depression: a PET study. |
AES, BA, LEDD, MADRS, MDRS, PD, UPDRS-III |
| 24 |
2012 |
Similar clinical and neuroimaging features in monozygotic twin pair with mutation in progranulin. |
PGRN |
| 25 |
2011 |
Impact of FDG-PET/CT in the management of lymphoma. |
--- |
| 26 |
2010 |
Comparative analysis of brain structure, metabolism, and cognition in myotonic dystrophy 1 and 2. |
BPF, VBM |
| 27 |
2010 |
Cortical control of thermoregulatory sympathetic activation. |
--- |
| 28 |
2010 |
Noninvasive testing, early surgery, and seizure freedom in tuberous sclerosis complex. |
MSI, TSC |
| 29 |
2010 |
Preoperative detection of prostate cancer: a comparison with 11C-choline PET, 18F-fluorodeoxyglucose PET and MR imaging. |
C-PET |
| 30 |
2009 |
Value of 18F-FDG-PET/PET-CT in differentiated thyroid carcinoma with radioiodine-negative whole-body scan: a meta-analysis. |
CI, CT, DTC, WBS |
| 31 |
2008 |
Implantation of olfactory ensheathing cells promotes neuroplasticity in murine models of stroke. |
OECs, SDF-1alpha |
| 32 |
2008 |
Improving observer variability in target delineation for gastro-oesophageal cancer--the role of (18F)fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography. |
GTV, PET-CT |
| 33 |
2008 |
[Value of 18F-fluorodeoxyglucose-PET in the diagonosis and monitoring of pulmonary sarcoidosis: a case report]. |
--- |
| 34 |
2007 |
PET-CT fusion in radiation management of patients with anorectal tumors. |
CT, CT-GTV, CT-PTV, OVs, PET-CT |
| 35 |
2007 |
Serum progastrin-releasing peptide levels followed by whole-body positron emission tomography detects early recurrence of small-cell lung cancer. |
ProGRP |
| 36 |
2005 |
Applications of PET in liver imaging. |
--- |
| 37 |
2005 |
Postoperative alteration of cerebral glucose metabolism in mesial temporal lobe epilepsy. |
MTLE, SPM |
| 38 |
2003 |
Fluorodeoxyglucose PET scan in pulmonary sarcoidosis during treatment with inhaled and oral corticosteroids. |
--- |
| 39 |
1998 |
Clinical utility of flumazenil-PET versus [18F]fluorodeoxyglucose-PET and MRI in refractory partial epilepsy. A prospective study in 100 patients. |
FMZ-PET |
| 40 |
1995 |
The use of PET in evaluating patients with primary brain tumours: is it useful? |
--- |
|
A Search Service for Abbreviation / Long Form
